LYPLA2P1 and endothelial dysfunction: Thus, it is suggested that intestinal injury, endothelial dysfunction, platelet abnormalities and enhanced apoptosis cause increased exposure of phospholipids or new epitopes, which are the origin of aPT, aPL and aPS/PT autoantibodies.